vTv Therapeutics (VTVT) Misses Q2 EPS by 81c
Tweet
Share
E-mailGet Alerts VTVT Hot Sheet
Join SI Premium – FREE
vTv Therapeutics (NASDAQ: VTVT) reported Q2 EPS of ($0.81).
For earnings history and earnings-related data on vTv Therapeutics (VTVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Bain Capital Exited Flash Memory Maker Kioxia, Executive Says - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
